APA (7th ed.) Citation

Wang, J., Dong, Y., Cao, F., Ran, R., Yin, Y., Li, Y., . . . Chu, Q. (2026). Prospective Multicenter Observational Study of Anlotinib in Advanced Non‐Small Cell Lung Cancer: Real‐World Evidence From China. Thoracic Cancer, 17(11), 1. https://doi.org/10.1111/1759-7714.70306

Chicago Style (17th ed.) Citation

Wang, Jinlin, et al. "Prospective Multicenter Observational Study of Anlotinib in Advanced Non‐Small Cell Lung Cancer: Real‐World Evidence From China." Thoracic Cancer 17, no. 11 (2026): 1. https://doi.org/10.1111/1759-7714.70306.

MLA (9th ed.) Citation

Wang, Jinlin, et al. "Prospective Multicenter Observational Study of Anlotinib in Advanced Non‐Small Cell Lung Cancer: Real‐World Evidence From China." Thoracic Cancer, vol. 17, no. 11, 2026, p. 1, https://doi.org/10.1111/1759-7714.70306.